• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Arteris Inc.

    2/10/22 4:53:10 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    SC 13G 1 d259969dsc13g.htm SC 13G SC 13G

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.     )*

     

     

    Arteris, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    04302A104

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 04302A104    Schedule 13G    Page 2 of 8

     

      1    

      Names of Reporting Persons

     

      Bayview Legacy, LLC (formerly Arteris IP, LLC)

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      0

       6  

      Shared Voting Power

     

      10,335,891

       7  

      Sole Dispositive Power

     

      0

       8  

      Shared Dispositive Power

     

      10,335,891

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      10,335,891

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      33.1%

    12  

      Type of Reporting Person

     

      OO


    CUSIP No. 04302A104    Schedule 13G    Page 3 of 8

     

      1    

      Names of Reporting Persons

     

      K. Charles Janac

      2  

      Check the Appropriate Box if a Member of a Group

     

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5    

      Sole Voting Power

     

      177,286

       6  

      Shared Voting Power

     

      10,335,891

       7  

      Sole Dispositive Power

     

      177,286

       8  

      Shared Dispositive Power

     

      10,335,891

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      10,513,177

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      33.6%

    12  

      Type of Reporting Person

     

      IN


    CUSIP No. 04302A104    Schedule 13G    Page 4 of 8

     

    ITEM 1.

    (a) Name of Issuer:

    Arteris, Inc. (the “Issuer”).

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    595 Millich Drive, Suite 200, Campbell, CA 95008

     

    ITEM 2.

    (a) Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    Bayview Legacy, LLC (formerly Arteris IP, LLC)

    K. Charles Janac

     

      (b)

    Address or Principal Business Office:

    The business address for each of Bayview Legacy, LLC and Mr. Janac is c/o Arteris, Inc., 595 Millich Drive, Suite 200, Campbell, California 95008.

     

      (c)

    Citizenship of each Reporting Person is:

    Bayview Legacy, LLC is organized under the laws of Delaware. Mr. Janac is a citizen of the United States.

     

      (d)

    Title of Class of Securities:

    Common Stock, par value $0.001 per share (“Common Stock”).

     

      (e)

    CUSIP Number:

    04302A104

    ITEM 3.

    Not applicable.


    CUSIP No. 04302A104    Schedule 13G    Page 5 of 8

     

    ITEM 4.

    Ownership.

    (a-c)

    The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2021, based upon 31,254,895 shares of Common Stock outstanding as of November 26, 2021, based on the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on December 1, 2021.

     

    Reporting Person   

    Amount

    beneficially

    owned

        

    Percent

    of class:

        Sole
    power
    to vote or
    to direct
    the vote:
         Shared
    power to
    vote or to
    direct the
    vote:
        

    Sole
    power to
    dispose or
    to direct
    the
    disposition

    of:

        

    Shared

    power to

    dispose or

    to direct

    the

    disposition

    of:

     

    Bayview Legacy, LLC

         10,335,891        33.1 %      0        10,335,891        0        10,335,891  

    K. Charles Janac

         10,513,177        33.6 %      177,286        10,335,891        177,286        10,335,891  

    Bayview Legacy, LLC is the record holder of 10,335,891 shares of Common Stock. Mr. Janac is the manager of Bayview Legacy, LLC and, as such, may be deemed to share beneficial ownership of the securities held of record by Bayview Legacy, LLC.

    Mr. Janac may also be deemed to share beneficial ownership of 177,286 shares of Common Stock, which includes of (i) 100,000 shares of Common Stock held of record by Mr. Janac and (ii) 77,286 shares of Common Stock held of record by the Janac Trust.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.


    CUSIP No. 04302A104    Schedule 13G    Page 6 of 8

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 04302A104    Schedule 13G    Page 7 of 8

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 10, 2022

     

    Bayview Legacy, LLC
    By:  

    /s/ K. Charles Janac

    Name:   K. Charles Janac
    Title:   Manager
    K. Charles Janac

    /s/ K. Charles Janac


    CUSIP No. 04302A104    Schedule 13G    Page 8 of 8

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    99    Joint Filing Agreement.
    Get the next $AIP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    8/6/2025$12.00 → $15.00Buy
    TD Cowen
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings

    $AIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Buy and set a new price target of $15.00 from $12.00 previously

    8/6/25 7:10:46 AM ET
    $AIP
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously

    9/1/23 7:31:29 AM ET
    $AIP
    Semiconductors
    Technology

    Cowen reiterated coverage on Arteris with a new price target

    Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously

    3/4/22 7:21:31 AM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2025 and provided estimated third quarter and updated full year 2025 guidance. "In the second quarter of 2025, we achieved record Annual Contract Value plus royalties of $69.1 million and exited the quarter with $99.3 million in Remaining Performance Obligations, with the latter representing a year-over-year increase of 28%," said K. Charles Janac, President and CEO of Arteris. "Looking ahead, we remain confident in Arteris' long-term growth opp

    8/5/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris To Provide FlexGen Smart NoC IP In Next-Generation AMD AI Chiplet Designs

    CAMPBELL, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a market reshaped by the compute demands of AI, Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced AMD (NASDAQ:AMD), a global leader in high-performance and adaptive computing, has licensed FlexGen network-on-chip (NoC) interconnect IP for its next generation of AI chiplet design. FlexGen, Arteris' smart NoC IP technology, will provide high-performance data transport in AMD chiplets powering AI across the company's broad portfolio which spans from data centers to edge and end devices. The strategic combination and interoperability of Arteris' FlexGe

    8/4/25 5:00:00 PM ET
    $AIP
    $AMD
    Semiconductors
    Technology

    Arteris Announces New Employment Inducement Grants

    CAMPBELL, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced that the compensation committee of the company's board of directors has granted an aggregate of 109,000 restricted stock units (RSUs) to four newly hired employees as inducement awards under the company's 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The effective RSU grant date was July 31, 2025, and it was approved by the company's board of directors. About Arteris Arteris is a global leader in system IP used in semiconductors to accelerate the creatio

    8/1/25 7:30:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bayview Legacy, Llc sold $655,995 worth of shares (50,000 units at $13.12) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    8/7/25 4:16:20 PM ET
    $AIP
    Semiconductors
    Technology

    Director Viana Antonio J sold $97,699 worth of shares (6,909 units at $14.14) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    8/7/25 4:15:00 PM ET
    $AIP
    Semiconductors
    Technology

    Director Raza Saiyed Atiq sold $825,205 worth of shares (63,118 units at $13.07) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    8/7/25 4:14:43 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Leadership Updates

    Live Leadership Updates

    View All

    Joachim Kunkel Joins Arteris Board of Directors

    CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where

    9/16/24 5:00:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    SEC Filings

    View All

    SEC Form 10-Q filed by Arteris Inc.

    10-Q - Arteris, Inc. (0001667011) (Filer)

    8/5/25 5:00:09 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    8/5/25 4:49:33 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    8/5/25 4:44:09 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Financials

    Live finance-specific insights

    View All

    Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2025 and provided estimated third quarter and updated full year 2025 guidance. "In the second quarter of 2025, we achieved record Annual Contract Value plus royalties of $69.1 million and exited the quarter with $99.3 million in Remaining Performance Obligations, with the latter representing a year-over-year increase of 28%," said K. Charles Janac, President and CEO of Arteris. "Looking ahead, we remain confident in Arteris' long-term growth opp

    8/5/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris to Announce Financial Results for the Second Quarter 2025 on Tuesday, August 5, 2025

    CAMPBELL, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating system-on-chip (SoC) creation, today announced it will release its financial results for the second quarter ended June 30, 2025, after market close on Tuesday, August 5, 2025. Management will host a conference call on Tuesday, August 5, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:  United States/Canada Toll Free:+1-800-717-1738 International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be available

    7/24/25 8:00:00 AM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the first quarter ended March 31, 2025 and provided estimated second quarter and updated full year 2025 guidance. "In the first quarter, we delivered record annual contract value plus royalties of $66.8 million and generated $2.7 million in positive free cash flow, driven by sustained demand for commercial semiconductor System IP products across enterprise computing, communications, and automotive semiconductors," said K. Charles Janac, President and CEO of Arteris. "Looking beyond the near-ter

    5/13/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Arteris Inc.

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    11/13/24 4:32:26 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G filed by Arteris Inc.

    SC 13G - Arteris, Inc. (0001667011) (Subject)

    6/27/24 3:46:24 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Arteris Inc. (Amendment)

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    1/24/24 4:05:55 PM ET
    $AIP
    Semiconductors
    Technology